Zdrowie i gospodarka · 16/03/2021
FDA to Host Public Meeting on Potential Medication Error Risks with Investigational Drug Container Labels
The FDA is hosting a public meeting to gather input from stakeholders on the risk of medication errors related to investigational drug labels and to discuss practices that minimize such errors.